What is Amphastar Pharmaceuticals, Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Amphastar Pharmaceuticals, Inc.'s reported free cash flow gives $74.60 per share. The share price was $29.06 on November 10, 2026, 61% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $42.01 | +45% |
| Base | 15.0% | 9.0% | $74.60 | +157% |
| Bull | 20.0% | 8.0% | $135.30 | +366% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $99.29 | $106.98 | $116.39 | $128.14 | $143.26 |
| 8.0% | $80.74 | $85.74 | $91.63 | $98.71 | $107.36 |
| 9.0% | $67.25 | $70.67 | $74.60 | $79.20 | $84.63 |
| 10.0% | $57.03 | $59.45 | $62.20 | $65.35 | $68.97 |
| 11.0% | $49.02 | $50.80 | $52.79 | $55.03 | $57.56 |
Where the presets come from
Base: years 1 to 5 grow at Amphastar Pharmaceuticals, Inc.'s revenue growth rate over the last 5 fiscal years (15.5% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions